| AGCTX | RSLBX | AGCTX / RSLBX | |
| Total Expense Ratio | 0.76 | 1.74 | 44% |
| Annual Report Gross Expense Ratio | 0.76 | 1.74 | 44% |
| Fund Existence | 10 years | 24 years | - |
| Gain YTD | 7.817 | 14.053 | 56% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 61.5M | 89B | 0% |
| Annual Yield % from dividends | 1.00 | 0.15 | 685% |
| Returns for 1 year | 9.09 | 13.50 | 67% |
| Returns for 3 years | 42.74 | 36.51 | 117% |
| Returns for 5 years | -3.07 | -8.16 | 38% |
| Returns for 10 years | 115.22 | 63.65 | 181% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RMOCX | 19.25 | 0.23 | +1.21% |
| Victory RS Mid Cap Growth C | |||
| CIVCX | 22.16 | 0.17 | +0.77% |
| American Funds Intl Vntg 529-E | |||
| GSYPX | 45.93 | 0.22 | +0.48% |
| Goldman Sachs Small Cap Value P | |||
| TRCVX | 35.26 | 0.16 | +0.46% |
| Nuveen Large Cap Value Idx Retire | |||
| JMNCX | 12.25 | -0.01 | -0.08% |
| JPMorgan Research Market Neutral C | |||